KSD-201 / Hengsai Bio - LARVOL DELTA

KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study (clinicaltrials.gov) - P1 | N=0 | Withdrawn | Sponsor: Kousai Bio Co., Ltd. | N=12 ➔ 0 | Trial completion date: Nov 2027 ➔ Mar 2026 | Not yet recruiting ➔ Withdrawn | Trial primary completion date: Nov 2026 ➔ Mar 2026

Enrollment change • Trial completion date • Trial primary completion date • Trial withdrawal • Clear Cell Renal Cell Carcinoma • Genito-urinary Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor

KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: Kousai Bio Co., Ltd. | Initiation date: Nov 2024 ➔ Oct 2025

Trial initiation date • Clear Cell Renal Cell Carcinoma • Genito-urinary Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor